Your Business Technology Events Calendar - Events, News and Networking Since 1998


| Event Details: |
Plan On Attending?  Click Here Bookmark and Share  to Share/Bookmark It!

Wednesday, October 30 2019
5:30pm - 8:30pm


MDG Boston presents... COMBINATION PRODUCTS FOR DRUG DELIVERY *What are the opportunities and advances in drug delivery? *What are the unique developmental challenges? *What are the opportunities for funding? Success requires collaboration between drug developers and device engineers. This is a challenge as these groups are accustomed to functioning under different types of regulations, design criteria, and controls. This panel is a mix of entrepreneurs, big pharma, and biotech developers who will discuss the medical and business challenges where delivery innovations can provide a unique solution. Entrepreneurs will discuss strategies for funding and development issues specific to drug delivery products. Speakers from big pharma and biotech will discuss challenges across the value chain of manufacturing and selling combination products globally. Benefits of Drug/Device Combinations:For many drugs, significant benefits could be obtained by combining the drug with a specialized delivery device, when compared to drugs which are primarily delivered by systemic means (e.g. orally, intravenously). Advantages of Combination Products:*Targeted delivery*Reduced dosing of expensive compounds*More control over the delivery profile*Greater patient convenience/complianceThe ultimate goal is to improve patient outcomes. The success of many new therapies is contingent on the development of effective delivery systems as traditional delivery methods won’t work for some compounds and biologics. Opportunities exist for combination products to extend the patent life of existing drugs on the market:A diverse set of scientific and engineering disciplines can converge to create elegant solutions to drug delivery problems. System level solutions may involve advanced materials, chemistry, sensors and software for monitoring and control. Join Us for a Discussion on the Growing Opportunities for Development ofCombination Products Oct 30 - Wednesday 5:30-8:30 PMRegis College, Fine Arts Center=================================================To Register : Earlybird Fees by Oct 23 Member/Alliance Partner - $35 Non-member - $45Regis Alumni - $25 Student (member) - $10 Student (non-member) - $15Gold Member - No Charge================================================= Who Should Attend:Physicians and engineers - Technological advances and development pathwaysPharma professionals, scientists and clinicians Novel - compounds with delivery challengesEntrepreneurs and investors - Innovative business opportunitiesSales & Marketing professionals - Go-to-market strategies and pricing models for combination products.Regulatory and clinical development - Testing, validation and monitoring of combination products. Panel : - Michael J. Cima, PhDProfessor, Materials Science and Engineering, Massachusetts Institute of Technology - Dan Groszmann, PhDPrincipal Engineer, Device Technology Innovation Center, Amgen - Maria Palasis, PhDPresident and Chief Executive Officer, Lyra Therapeutics - Rami Tzafriri, PhDDirector of Research and Innovation, CBSET - Maria Shepherd - MODERATOR President and CEO, Medi-Vantage

Email Address:  
   Sign up to be reminded via email, which is delivered ONLY ONCE the weekend BEFORE this event occurs. (We encourage the use of your personal/home email address)

Plan On Attending? 
Click Here
to Share with Your Network(s) and/or Bookmark It!

Download as iCalendar (iCal) Format For Your Personal Outlook or Mobile Device Calendar!

First Learned About This Event At Please Mention Us When You Register and Attend - Thank You!
All content and formatting Copyright � 1998-2010 -
Event Address:  
City, State or Zip: